Kingdon Capital Management »

Bridgebio Pharma shares owned by Kingdon Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Kingdon Capital Management from 13F filings

Historical chart of Kingdon Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Kingdon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Kingdon Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $4.6M 268k 17.20
2023-03-31 $635k 38k 16.58
2021-12-31 $1.7M 100k 16.68

More positions owned by Kingdon Capital Management

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Blackstone Group Inc Com Cl A Put Option (BX)
Sherwin-Williams Company Call Option (SHW)
Api Group Corp Com Stk (APG)
Catalent (CTLT)
Rapt Therapeutics (RAPT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Teck Resources CL B (TECK)
Meta Platforms Cl A (META)
Ftai Aviation SHS (FTAI)
Union Pacific Corporation (UNP)
Molson Coors Beverage CL B (TAP)
Synchrony Financial Put Option (SYF)
Bank of America Corporation Call Option (BAC)
Dell Technologies CL C (DELL)

View all positions for Kingdon Capital Management

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
Aisling Capital Management
Laurion Capital Management
Cormorant Asset Management
Goldman Sachs Group
Lord, Abbett & Co
Frazier Life Sciences Management
Alliancebernstein
Perceptive Advisors
Citigroup
Wellington Management Company
Hillhouse Capital Advisors
Norges Bank Investment Management

View all funds holding Bridgebio Pharma